Literature DB >> 8047717

Oxidative metabolism of pulmonary phagocytes in acute pneumonia.

K Dalhoff1, J Braun, H Kothe, M Körber, M Pein, K J Wiessmann.   

Abstract

The oxidative response of activated phagocytes is a primary host defense mechanism in pneumonia, but is in addition capable of causing tissue damage. We evaluated amount and significance of the local oxidant production in immunocompetent and immunocompromised pneumonia patients; the relative contribution of neutrophils and alveolar macrophages to the total oxidant load was differentiated using chemiluminescence (CL) with different amplifiers. Luminol-enhanced CL correlated to neutrophil percentage and myeloperoxidase levels in the bronchoalveolar lavage and was markedly increased in both pneumonia groups. Lucigenin-enhanced CL was produced by both phagocyte types and not significantly increased. In both pneumonia groups elevated levels of serum proteins indicated severe alveolocapillary leakage. In conclusion the oxidative response in acute pneumonia was mainly due to neutrophil recruitment and activation; this defense mechanism was preserved even in severely immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047717     DOI: 10.1159/000196326

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Role of interleukin-8 in community-acquired pneumonia: relation to microbial load and pulmonary function.

Authors:  S Bohnet; U Kötschau; J Braun; K Dalhoff
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

2.  Delayed Pulmonary Apoptosis of Diet-Induced Obesity Mice following Escherichia coli Infection through the Mitochondrial Apoptotic Pathway.

Authors:  Fengyuan Wang; Zhicai Zuo; Zhuangzhi Yang; Kejie Chen; Jing Fang; Hengmin Cui; Gang Shu; Yi Zhou; Yi Geng; Ping Ouyang
Journal:  Oxid Med Cell Longev       Date:  2019-10-22       Impact factor: 6.543

3.  Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity.

Authors:  Bernhard Schaaf; Cornelia Liebau; Volkhard Kurowski; Daniel Droemann; Klaus Dalhoff
Journal:  BMC Pulm Med       Date:  2008-08-12       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.